Briggs Morrison
Impact in
- Pharmacology top 1%
- Inflammatory mediators and NSAID effects
- Pharmacogenetics and Drug Metabolism
- Biochemistry top 2%
- Eicosanoids and Hypertension Pharmacology
Papers in
- Oncology 5
- Cancer-related Molecular Pathways 3
- HER2/EGFR in Cancer Research 2
- Colorectal Cancer Treatments and Studies 2
- Co-authors
- Barry J. Gertz (2 shared papers)Kenneth C. Lasseter (1 shared paper)Francesca Catella-Lawson (1 shared paper)Brendan McAdam (1 shared paper)Shiv Kapoor (1 shared paper)Dean A. Kujubu (1 shared paper)Hui Quan (1 shared paper)Lisa M. Antes (1 shared paper)
- Journals
- Clinical Cancer Research (2 papers)Therapeutic Innovation & Regulatory Science (2 papers)International Journal of Cancer (2 papers)Journal of Clinical Oncology (2 papers)Journal of Biological Chemistry (2 papers)
- Partner nations
- United StatesUnited KingdomSwitzerland
In The Last Decade
Briggs Morrison
23 papers receiving 1.4k citations
Briggs Morrison's Hit Papers
Peers
Comparison fields: 5 of 121
- Pharmacology 578
- Biochemistry 221
- Pharmacology 110
- Immunology 176
- Cardiology and Cardiovascular Medicine 166
Countries citing papers authored by Briggs Morrison
This map shows the geographic impact of Briggs Morrison's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Briggs Morrison with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Briggs Morrison more than expected).
Fields of papers citing papers by Briggs Morrison
This network shows the impact of papers produced by Briggs Morrison. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Briggs Morrison. The network helps show where Briggs Morrison may publish in the future.
Co-authors
The 25 scholars most cited alongside Briggs Morrison, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 24 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Effects of Specific Inhibition of Cyclooxygenase-2 on Sodium Balance, Hemodynamics, and Vasoactive Eicosanoids Hit paper breakdown → | 1999 | 504 |
| 2 | 1996 | 147 | |
| 3 | 1995 | 135 | |
| 4 | Effect of specific COX-2 inhibition in osteoarthritis of the knee: a 6 week double blind, placebo controlled pilot study of rofecoxib. Rofecoxib Osteoarthritis Pilot Study Group. | 1999 | 133 |
| 5 | A Phase I trial of the farnesyltransferase inhibitor L-778,123 and radiotherapy for locally advanced lung and head and neck cancer. | 2002 | 79 |
| 6 | 2004 | 72 | |
| 7 | 2011 | 63 | |
| 8 | 2002 | 57 | |
| 9 | 1953 | 48 | |
| 10 | 2000 | 47 | |
| 11 | 1999 | 46 | |
| 12 | 1992 | 39 | |
| 13 | 2018 | 37 | |
| 14 | 1989 | 29 | |
| 15 | 2012 | 15 | |
| 16 | 2013 | 14 | |
| 17 | 2012 | 13 | |
| 18 | 2012 | 11 | |
| 19 | 1999 | 8 | |
| 20 | 1994 | 5 |
About Briggs Morrison
Briggs Morrison is a scholar working on Oncology, Public Health, Environmental and Occupational Health, Radiology, Nuclear Medicine and Imaging, Molecular Biology and Pharmacology, having authored 24 papers that have together received 1.5k indexed citations. Recurring topics across this work include Inflammatory mediators and NSAID effects (4 papers), Cancer-related Molecular Pathways (3 papers), Health Systems, Economic Evaluations, Quality of Life (3 papers), Monoclonal and Polyclonal Antibodies Research (3 papers), Immunotherapy and Immune Responses (3 papers), Meta-analysis and systematic reviews (3 papers), HER2/EGFR in Cancer Research (2 papers) and Colorectal Cancer Treatments and Studies (2 papers). The work is most often cited by research in Pharmacology (578 citations), Biochemistry (221 citations), Pharmacology (110 citations), Immunology (176 citations) and Cardiology and Cardiovascular Medicine (166 citations). Briggs Morrison has collaborated with scholars based in United States, United Kingdom and Switzerland. Frequent co-authors include Barry J. Gertz, Kenneth C. Lasseter, Francesca Catella-Lawson, Brendan McAdam, Shiv Kapoor, Dean A. Kujubu, Hui Quan, Lisa M. Antes, Garret A. FitzGerald and Philip Leder. Their work appears in journals such as Clinical Cancer Research, Therapeutic Innovation & Regulatory Science, International Journal of Cancer, Journal of Clinical Oncology and Journal of Biological Chemistry.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.